Otrexup
- Product NDC
- 54436-020
- 11-digit product format
- 544360020
- Labeler code
- 54436
- Product ID
- 54436-020_2d07eb50-d314-a6a0-e063-6394a90ac970
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- methotrexate
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Antares Pharma, Inc.
- Application
- NDA204824
- Marketing category
- NDA
- Marketing start
- 2013-10-11
- Marketing end
- 2027-04-30
- Substance
- METHOTREXATE
- Active strength
- 20 mg/.4mL
- Pharmacologic classes
- Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
- NDC exclude flag
- No
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N204824-001 | OTREXUP | METHOTREXATE | 10MG/0.4ML (10MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2013-10-11 | |
| N204824-002 | OTREXUP | METHOTREXATE | 15MG/0.4ML (15MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2013-10-11 | |
| N204824-003 | OTREXUP | METHOTREXATE | 20MG/0.4ML (20MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2013-10-11 | |
| N204824-004 | OTREXUP | METHOTREXATE | 25MG/0.4ML (25MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2013-10-11 | |
| N204824-005 | OTREXUP | METHOTREXATE | 7.5MG/0.4ML (7.5MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2014-11-07 | |
| N204824-006 | OTREXUP | METHOTREXATE | 12.5MG/0.4ML (12.5MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2016-03-24 | |
| N204824-007 | OTREXUP | METHOTREXATE | 17.5MG/0.4ML (17.5MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2016-03-24 | |
| N204824-008 | OTREXUP | METHOTREXATE | 22.5MG/0.4ML (22.5MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2016-03-24 | |
| N204824-009 | OTREXUP PFS | METHOTREXATE | 10MG/0.4ML (10MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-05-31 | |
| N204824-010 | OTREXUP PFS | METHOTREXATE | 15MG/0.6ML (15MG/0.6ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-05-31 | |
| N204824-011 | OTREXUP PFS | METHOTREXATE | 17.5MG/0.7ML (17.5MG/0.7ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-05-31 | |
| N204824-012 | OTREXUP PFS | METHOTREXATE | 20MG/0.8ML (20MG/0.8ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-05-31 | |
| N204824-013 | OTREXUP PFS | METHOTREXATE | 22.5MG/0.9ML (22.5MG/0.9ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-05-31 | |
| N204824-014 | OTREXUP PFS | METHOTREXATE | 25MG/ML (25MG/ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-05-31 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N204824-001 | 11446441 | 2026-01-24 | Drug product | 2022-10-19 | |
| N204824-001 | 8562564 | 2026-01-24 | Drug product | 2013-11-04 | |
| N204824-001 | 9533102 | 2026-01-24 | Drug product | 2017-02-02 | |
| N204824-001 | 9629959 | 2026-01-24 | Drug product | 2017-05-25 | |
| N204824-001 | 8021335 | 2026-10-04 | Drug product | 2013-11-04 | |
| N204824-001 | 10709844 | 2029-03-10 | Drug product | 2020-08-14 | |
| N204824-001 | 11684723 | 2029-03-10 | Drug product | 2023-07-19 | |
| N204824-001 | 9867949 | 2029-03-10 | Drug product | 2020-08-14 | |
| N204824-001 | 11497753 | 2030-03-19 | Drug product | 2022-12-13 | |
| N204824-001 | 12357642 | 2030-03-19 | Drug product | 2025-08-15 | |
| N204824-001 | 8480631 | 2030-03-19 | U-1442 | Drug product | 2013-11-04 |
| N204824-001 | 8579865 | 2030-03-19 | U-1442 | Drug product | 2013-11-21 |
| N204824-001 | 8945063 | 2030-03-19 | U-1442 | Drug product | 2015-03-02 |
| N204824-001 | 9421333 | 2030-03-19 | U-1442 | Drug product | 2016-09-21 |
| N204824-001 | 8814834 | 2031-05-27 | Drug product | 2020-08-14 | |
| N204824-002 | 11446441 | 2026-01-24 | Drug product | 2022-10-19 | |
| N204824-002 | 8562564 | 2026-01-24 | Drug product | 2013-11-04 | |
| N204824-002 | 9533102 | 2026-01-24 | Drug product | 2017-02-02 | |
| N204824-002 | 9629959 | 2026-01-24 | Drug product | 2017-05-25 | |
| N204824-002 | 8021335 | 2026-10-04 | Drug product | 2013-11-04 | |
| N204824-002 | 10709844 | 2029-03-10 | Drug product | 2020-08-14 | |
| N204824-002 | 11684723 | 2029-03-10 | Drug product | 2023-07-19 | |
| N204824-002 | 9867949 | 2029-03-10 | Drug product | 2020-08-14 | |
| N204824-002 | 11497753 | 2030-03-19 | Drug product | 2022-12-13 | |
| N204824-002 | 12357642 | 2030-03-19 | Drug product | 2025-08-15 | |
| N204824-002 | 8480631 | 2030-03-19 | U-1442 | Drug product | |
| N204824-002 | 8579865 | 2030-03-19 | U-1442 | Drug product | 2013-11-21 |
| N204824-002 | 8945063 | 2030-03-19 | U-1442 | Drug product | 2015-03-02 |
| N204824-002 | 9421333 | 2030-03-19 | U-1442 | Drug product | 2016-09-21 |
| N204824-002 | 8814834 | 2031-05-27 | Drug product | 2020-08-14 | |
| N204824-003 | 11446441 | 2026-01-24 | Drug product | 2022-10-19 | |
| N204824-003 | 8562564 | 2026-01-24 | Drug product | 2013-11-04 | |
| N204824-003 | 9533102 | 2026-01-24 | Drug product | 2017-02-02 | |
| N204824-003 | 9629959 | 2026-01-24 | Drug product | 2017-05-25 | |
| N204824-003 | 8021335 | 2026-10-04 | Drug product | 2013-11-04 | |
| N204824-003 | 10709844 | 2029-03-10 | Drug product | 2020-08-14 | |
| N204824-003 | 11684723 | 2029-03-10 | Drug product | 2023-07-19 | |
| N204824-003 | 9867949 | 2029-03-10 | Drug product | 2020-08-14 | |
| N204824-003 | 11497753 | 2030-03-19 | Drug product | 2022-12-13 | |
| N204824-003 | 12357642 | 2030-03-19 | Drug product | 2025-08-15 | |
| N204824-003 | 8480631 | 2030-03-19 | U-1442 | Drug product | |
| N204824-003 | 8579865 | 2030-03-19 | U-1442 | Drug product | 2013-11-21 |
| N204824-003 | 8945063 | 2030-03-19 | U-1442 | Drug product | 2015-03-02 |
| N204824-003 | 9421333 | 2030-03-19 | U-1442 | Drug product | 2016-09-21 |
| N204824-003 | 8814834 | 2031-05-27 | Drug product | 2020-08-14 | |
| N204824-004 | 11446441 | 2026-01-24 | Drug product | 2022-10-19 | |
| N204824-004 | 8562564 | 2026-01-24 | Drug product | 2013-11-04 | |
| N204824-004 | 9533102 | 2026-01-24 | Drug product | 2017-02-02 | |
| N204824-004 | 9629959 | 2026-01-24 | Drug product | 2017-05-25 | |
| N204824-004 | 8021335 | 2026-10-04 | Drug product | 2013-11-04 | |
| N204824-004 | 10709844 | 2029-03-10 | Drug product | 2020-08-14 | |
| N204824-004 | 11684723 | 2029-03-10 | Drug product | 2023-07-19 | |
| N204824-004 | 9867949 | 2029-03-10 | Drug product | 2020-08-14 | |
| N204824-004 | 11497753 | 2030-03-19 | Drug product | 2022-12-13 | |
| N204824-004 | 12357642 | 2030-03-19 | Drug product | 2025-08-15 | |
| N204824-004 | 8480631 | 2030-03-19 | U-1442 | Drug product | |
| N204824-004 | 8579865 | 2030-03-19 | U-1442 | Drug product | 2013-11-21 |
| N204824-004 | 8945063 | 2030-03-19 | U-1442 | Drug product | 2015-03-02 |
| N204824-004 | 9421333 | 2030-03-19 | U-1442 | Drug product | 2016-09-21 |
| N204824-004 | 8814834 | 2031-05-27 | Drug product | 2020-08-14 | |
| N204824-005 | 11446441 | 2026-01-24 | Drug product | 2022-10-19 | |
| N204824-005 | 8562564 | 2026-01-24 | Drug product | 2014-12-02 | |
| N204824-005 | 9533102 | 2026-01-24 | Drug product | 2017-02-02 | |
| N204824-005 | 9629959 | 2026-01-24 | Drug product | 2017-05-25 | |
| N204824-005 | 8021335 | 2026-10-04 | Drug product | 2014-12-02 | |
| N204824-005 | 10709844 | 2029-03-10 | Drug product | 2020-08-14 | |
| N204824-005 | 11684723 | 2029-03-10 | Drug product | 2023-07-19 | |
| N204824-005 | 9867949 | 2029-03-10 | Drug product | 2020-08-14 | |
| N204824-005 | 11497753 | 2030-03-19 | Drug product | 2022-12-13 | |
| N204824-005 | 12357642 | 2030-03-19 | Drug product | 2025-08-15 | |
| N204824-005 | 8480631 | 2030-03-19 | U-1442 | Drug product | 2014-12-02 |
| N204824-005 | 8579865 | 2030-03-19 | U-1442 | Drug product | 2014-12-02 |
| N204824-005 | 8945063 | 2030-03-19 | U-1442 | Drug product | 2015-03-02 |
| N204824-005 | 9421333 | 2030-03-19 | U-1442 | Drug product | 2016-09-21 |
| N204824-005 | 8814834 | 2031-05-27 | Drug product | 2020-08-14 | |
| N204824-006 | 11446441 | 2026-01-24 | Drug product | 2022-10-19 | |
| N204824-006 | 8562564 | 2026-01-24 | Drug product | 2016-06-01 | |
| N204824-006 | 9533102 | 2026-01-24 | Drug product | 2017-02-02 | |
| N204824-006 | 9629959 | 2026-01-24 | Drug product | 2017-05-25 | |
| N204824-006 | 8021335 | 2026-10-04 | Drug product | 2016-06-01 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N204824-001 | OTREXUP | 10MG/0.4ML (10MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2013-10-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-002 | OTREXUP | 15MG/0.4ML (15MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2013-10-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-003 | OTREXUP | 20MG/0.4ML (20MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2013-10-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-004 | OTREXUP | 25MG/0.4ML (25MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2013-10-11 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-005 | OTREXUP | 7.5MG/0.4ML (7.5MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2014-11-07 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-006 | OTREXUP | 12.5MG/0.4ML (12.5MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2016-03-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-007 | OTREXUP | 17.5MG/0.4ML (17.5MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2016-03-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-008 | OTREXUP | 22.5MG/0.4ML (22.5MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2016-03-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-009 | OTREXUP PFS | 10MG/0.4ML (10MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-05-31 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-010 | OTREXUP PFS | 15MG/0.6ML (15MG/0.6ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-05-31 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-011 | OTREXUP PFS | 17.5MG/0.7ML (17.5MG/0.7ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-05-31 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-012 | OTREXUP PFS | 20MG/0.8ML (20MG/0.8ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-05-31 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-013 | OTREXUP PFS | 22.5MG/0.9ML (22.5MG/0.9ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-05-31 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-014 | OTREXUP PFS | 25MG/ML (25MG/ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-05-31 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204824-001 | OTREXUP | 10MG/0.4ML (10MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2013-10-11 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204824-002 | OTREXUP | 15MG/0.4ML (15MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2013-10-11 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204824-003 | OTREXUP | 20MG/0.4ML (20MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2013-10-11 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204824-004 | OTREXUP | 25MG/0.4ML (25MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2013-10-11 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204824-005 | OTREXUP | 7.5MG/0.4ML (7.5MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2014-11-07 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204824-006 | OTREXUP | 12.5MG/0.4ML (12.5MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2016-03-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204824-007 | OTREXUP | 17.5MG/0.4ML (17.5MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2016-03-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204824-008 | OTREXUP | 22.5MG/0.4ML (22.5MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2016-03-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204824-009 | OTREXUP PFS | 10MG/0.4ML (10MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-05-31 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204824-010 | OTREXUP PFS | 15MG/0.6ML (15MG/0.6ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-05-31 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204824-011 | OTREXUP PFS | 17.5MG/0.7ML (17.5MG/0.7ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-05-31 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204824-012 | OTREXUP PFS | 20MG/0.8ML (20MG/0.8ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-05-31 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204824-013 | OTREXUP PFS | 22.5MG/0.9ML (22.5MG/0.9ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-05-31 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N204824-014 | OTREXUP PFS | 25MG/ML (25MG/ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-05-31 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204824-001 | OTREXUP | 10MG/0.4ML (10MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2013-10-11 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204824-002 | OTREXUP | 15MG/0.4ML (15MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2013-10-11 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204824-003 | OTREXUP | 20MG/0.4ML (20MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2013-10-11 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204824-004 | OTREXUP | 25MG/0.4ML (25MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2013-10-11 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204824-005 | OTREXUP | 7.5MG/0.4ML (7.5MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2014-11-07 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204824-006 | OTREXUP | 12.5MG/0.4ML (12.5MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2016-03-24 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204824-007 | OTREXUP | 17.5MG/0.4ML (17.5MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2016-03-24 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204824-008 | OTREXUP | 22.5MG/0.4ML (22.5MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2016-03-24 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204824-009 | OTREXUP PFS | 10MG/0.4ML (10MG/0.4ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-05-31 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204824-010 | OTREXUP PFS | 15MG/0.6ML (15MG/0.6ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-05-31 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204824-011 | OTREXUP PFS | 17.5MG/0.7ML (17.5MG/0.7ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-05-31 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N204824-012 | OTREXUP PFS | 20MG/0.8ML (20MG/0.8ML) | SOLUTION / SUBCUTANEOUS | RLD | 2017-05-31 | 31067a03dcf5… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N204824-001 | 11446441 | 2026-01-24 | Drug product | 2022-10-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-001 | 8562564 | 2026-01-24 | Drug product | 2013-11-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-001 | 9533102 | 2026-01-24 | Drug product | 2017-02-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-001 | 9629959 | 2026-01-24 | Drug product | 2017-05-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-001 | 8021335 | 2026-10-04 | Drug product | 2013-11-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-001 | 10709844 | 2029-03-10 | Drug product | 2020-08-14 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-001 | 11684723 | 2029-03-10 | Drug product | 2023-07-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-001 | 9867949 | 2029-03-10 | Drug product | 2020-08-14 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-001 | 11497753 | 2030-03-19 | Drug product | 2022-12-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-001 | 12357642 | 2030-03-19 | Drug product | 2025-08-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-001 | 8480631 | 2030-03-19 | U-1442 | Drug product | 2013-11-04 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204824-001 | 8579865 | 2030-03-19 | U-1442 | Drug product | 2013-11-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204824-001 | 8945063 | 2030-03-19 | U-1442 | Drug product | 2015-03-02 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204824-001 | 9421333 | 2030-03-19 | U-1442 | Drug product | 2016-09-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204824-001 | 8814834 | 2031-05-27 | Drug product | 2020-08-14 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-002 | 11446441 | 2026-01-24 | Drug product | 2022-10-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-002 | 8562564 | 2026-01-24 | Drug product | 2013-11-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-002 | 9533102 | 2026-01-24 | Drug product | 2017-02-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-002 | 9629959 | 2026-01-24 | Drug product | 2017-05-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-002 | 8021335 | 2026-10-04 | Drug product | 2013-11-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-002 | 10709844 | 2029-03-10 | Drug product | 2020-08-14 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-002 | 11684723 | 2029-03-10 | Drug product | 2023-07-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-002 | 9867949 | 2029-03-10 | Drug product | 2020-08-14 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-002 | 11497753 | 2030-03-19 | Drug product | 2022-12-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-002 | 12357642 | 2030-03-19 | Drug product | 2025-08-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-002 | 8480631 | 2030-03-19 | U-1442 | Drug product | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-002 | 8579865 | 2030-03-19 | U-1442 | Drug product | 2013-11-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204824-002 | 8945063 | 2030-03-19 | U-1442 | Drug product | 2015-03-02 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204824-002 | 9421333 | 2030-03-19 | U-1442 | Drug product | 2016-09-21 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N204824-002 | 8814834 | 2031-05-27 | Drug product | 2020-08-14 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-003 | 11446441 | 2026-01-24 | Drug product | 2022-10-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-003 | 8562564 | 2026-01-24 | Drug product | 2013-11-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-003 | 9533102 | 2026-01-24 | Drug product | 2017-02-02 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-003 | 9629959 | 2026-01-24 | Drug product | 2017-05-25 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-003 | 8021335 | 2026-10-04 | Drug product | 2013-11-04 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-003 | 10709844 | 2029-03-10 | Drug product | 2020-08-14 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-003 | 11684723 | 2029-03-10 | Drug product | 2023-07-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-003 | 9867949 | 2029-03-10 | Drug product | 2020-08-14 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-003 | 11497753 | 2030-03-19 | Drug product | 2022-12-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N204824-003 | 12357642 | 2030-03-19 | Drug product | 2025-08-15 | caaa826d4ba7… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Otrexup
Active Ingredients#
| Ingredient | Strength |
|---|---|
| METHOTREXATE | 20 mg/.4mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| YL5FZ2Y5U1 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1441402 | Internal RxNorm lookup |
| 1441407 | Internal RxNorm lookup |
| 1441411 | Internal RxNorm lookup |
| 1441413 | Internal RxNorm lookup |
| 1441416 | Internal RxNorm lookup |
| 1441418 | Internal RxNorm lookup |
| 1441422 | Internal RxNorm lookup |
| 1441424 | Internal RxNorm lookup |
| 1594757 | Internal RxNorm lookup |
| 1594759 | Internal RxNorm lookup |
| 1747179 | Internal RxNorm lookup |
| 1747181 | Internal RxNorm lookup |
| 1747185 | Internal RxNorm lookup |
| 1747187 | Internal RxNorm lookup |
| 1747192 | Internal RxNorm lookup |
| 1747194 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 2eb9a854-4fbc-9bbe-3199-41fc1018a1f0 | Product name | 9 | 20250224 |
| 3082de91-569a-4d57-b379-acbf37f1d5c3 | Product name | 1 | 20210312 |
| f76135bc-a210-42d9-851b-1b73cbaccdb3 | Product name | 1 | 20200511 |
| 423544b2-e325-49ee-8910-4c5dfe41906f | Product name | 1 | 20181120 |
| c9fd924b-0a8d-4d53-bf70-11070e24e4dd | Product name | 2 | 20181120 |
| ce1e7cc6-4850-4cb1-8dde-8010b2fbc359 | Product name | 1 | 20181120 |
| eb454f54-2806-4c31-a08b-8dcb08261099 | Product name | 2 | 20181120 |
| d9cebc09-c68d-46f5-bdcd-fd82e945cc27 | Product name | 1 | 20170705 |
| 16ba0c1e-2371-48a4-8b4c-a9a338dfe1f3 | Product name | 2 | 20160504 |
| 88514aea-9d58-4ed2-b135-9811fb14c8fb | Product name | 1 | 20141209 |
| 0eba90a2-1cca-7e7b-28a5-85a09e2bc9a4 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54436-020-01 | Otrexup | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 15 | |
| 54436-020-01 | Otrexup | 0.4 mL in 1 SYRINGE | INJECTION, SOLUTION | 0.4 | 15 | |
| 54436-020-02 | Otrexup | 0.4 mL in 1 SYRINGE | INJECTION, SOLUTION | 0.4 | 15 | |
| 54436-020-03 | Otrexup | 0.4 mL in 1 SYRINGE | INJECTION, SOLUTION | 0.4 | 15 | |
| 54436-020-03 | Otrexup | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 15 | |
| 54436-020-04 | Otrexup | 4 in 1 CARTON | INJECTION, SOLUTION | 4 | 15 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 54436-020-02 | ML - Milliliter | 54436-020 | 614b54e8-fe92-4e4d-b650-1f273a1f34ad | 1 | 2014-01-04 |
| 54436-020-04 | ML - Milliliter | 54436-020 | 62cc2dc3-7391-4ad6-9e26-252b1c5497c8 | 1 | 2014-01-04 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| METHOTREXATE | ACTIVE INGREDIENT | YL5FZ2Y5U1 | OTREXUP (METHOTREXATE) INJECTION, SOLUTION [ANTARES PHARMA, INC.] | 3 | |
| METHOTREXATE | ACTIVE MOIETY | YL5FZ2Y5U1 | OTREXUP (METHOTREXATE) INJECTION, SOLUTION [ANTARES PHARMA, INC.] | 3 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | OTREXUP (METHOTREXATE) INJECTION, SOLUTION [ANTARES PHARMA, INC.] | 3 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | OTREXUP (METHOTREXATE) INJECTION, SOLUTION [ANTARES PHARMA, INC.] | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Otrexup | METHOTREXATE | Antares Pharma, Inc. | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 2025-01-31 | Boxed warning, Warnings, Adverse reactions | 204824 NDA204824 54436-020 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1441402 | methotrexate 10 MG in 0.4 ML Auto-Injector | PSN | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1747179 | methotrexate 12.5 MG in 0.4 ML Auto-Injector | PSN | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441411 | methotrexate 15 MG in 0.4 ML Auto-Injector | PSN | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1747185 | methotrexate 17.5 MG in 0.4 ML Auto-Injector | PSN | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441416 | methotrexate 20 MG in 0.4 ML Auto-Injector | PSN | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1747192 | methotrexate 22.5 MG in 0.4 ML Auto-Injector | PSN | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441422 | methotrexate 25 MG in 0.4 ML Auto-Injector | PSN | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1594757 | methotrexate 7.5 MG in 0.4 ML Auto-Injector | PSN | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441407 | Otrexup 10 MG in 0.4 ML Auto-Injector | PSN | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1747181 | Otrexup 12.5 MG in 0.4 ML Auto-Injector | PSN | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441413 | Otrexup 15 MG in 0.4 ML Auto-Injector | PSN | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1747187 | Otrexup 17.5 MG in 0.4 ML Auto-Injector | PSN | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441418 | Otrexup 20 MG in 0.4 ML Auto-Injector | PSN | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1747194 | Otrexup 22.5 MG in 0.4 ML Auto-Injector | PSN | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441424 | Otrexup 25 MG in 0.4 ML Auto-Injector | PSN | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1594759 | Otrexup 7.5 MG in 0.4 ML Auto-Injector | PSN | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1594759 | 0.4 ML methotrexate 18.8 MG/ML Auto-Injector [Otrexup] | SBD | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441407 | 0.4 ML methotrexate 25 MG/ML Auto-Injector [Otrexup] | SBD | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1747181 | 0.4 ML methotrexate 31.3 MG/ML Auto-Injector [Otrexup] | SBD | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441413 | 0.4 ML methotrexate 37.5 MG/ML Auto-Injector [Otrexup] | SBD | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1747187 | 0.4 ML methotrexate 43.8 MG/ML Auto-Injector [Otrexup] | SBD | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441418 | 0.4 ML methotrexate 50 MG/ML Auto-Injector [Otrexup] | SBD | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1747194 | 0.4 ML methotrexate 56.3 MG/ML Auto-Injector [Otrexup] | SBD | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441424 | 0.4 ML methotrexate 62.5 MG/ML Auto-Injector [Otrexup] | SBD | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1594757 | 0.4 ML methotrexate 18.8 MG/ML Auto-Injector | SCD | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441402 | 0.4 ML methotrexate 25 MG/ML Auto-Injector | SCD | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1747179 | 0.4 ML methotrexate 31.3 MG/ML Auto-Injector | SCD | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441411 | 0.4 ML methotrexate 37.5 MG/ML Auto-Injector | SCD | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1747185 | 0.4 ML methotrexate 43.8 MG/ML Auto-Injector | SCD | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441416 | 0.4 ML methotrexate 50 MG/ML Auto-Injector | SCD | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1747192 | 0.4 ML methotrexate 56.3 MG/ML Auto-Injector | SCD | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441422 | 0.4 ML methotrexate 62.5 MG/ML Auto-Injector | SCD | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1594759 | 0.4 ML Otrexup 18.8 MG/ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441407 | 0.4 ML Otrexup 25 MG/ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1747181 | 0.4 ML Otrexup 31.3 MG/ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441413 | 0.4 ML Otrexup 37.5 MG/ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1747187 | 0.4 ML Otrexup 43.8 MG/ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441418 | 0.4 ML Otrexup 50 MG/ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1747194 | 0.4 ML Otrexup 56.3 MG/ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441424 | 0.4 ML Otrexup 62.5 MG/ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441416 | methotrexate (as methotrexate sodium) 50 MG/ML 0.4 ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441402 | methotrexate 10 MG per 0.4 ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1747179 | methotrexate 12.5 MG per 0.4 ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441411 | methotrexate 15 MG per 0.4 ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1747185 | methotrexate 17.5 MG per 0.4 ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441416 | methotrexate 20 MG per 0.4 ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1747192 | methotrexate 22.5 MG per 0.4 ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441422 | methotrexate 25 MG per 0.4 ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1594757 | methotrexate 7.5 MG per 0.4 ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441407 | Otrexup 10 MG per 0.4 ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1747181 | Otrexup 12.5 MG per 0.4 ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441413 | Otrexup 15 MG per 0.4 ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1747187 | Otrexup 17.5 MG per 0.4 ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441418 | Otrexup 20 MG per 0.4 ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1747194 | Otrexup 22.5 MG per 0.4 ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441424 | Otrexup 25 MG per 0.4 ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441407 | Otrexup 25 MG/ML in 0.4 ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441413 | Otrexup 37.5 MG/ML in 0.4 ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441418 | Otrexup 50 MG/ML in 0.4 ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1441424 | Otrexup 62.5 MG/ML in 0.4 ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
| 1594759 | Otrexup 7.5 MG per 0.4 ML Auto-Injector | SY | 9ab8ce16-f7de-41d4-a4c8-1c742621b6d5 | 15 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 54436-020-01 | 54436002001 | 1 SYRINGE in 1 CARTON (54436-020-01) / .4 mL in 1 SYRINGE | 1 syringe | 2013-10-11 | 2027-04-30 | No | No | Current |
| 54436-020-02 | 54436002002 | 0.4 mL in 1 SYRINGE | 0.4 ml | Historical | ||||
| 54436-020-03 | 54436002003 | 1 SYRINGE in 1 CARTON (54436-020-03) / .4 mL in 1 SYRINGE | 1 syringe | 2013-10-11 | 2027-04-30 | Yes | No | Current |
| 54436-020-04 | 54436002004 | 4 SYRINGE in 1 CARTON (54436-020-04) / .4 mL in 1 SYRINGE (54436-020-02) | 4 syringe | 2013-10-11 | 2027-04-30 | No | No | Current |